Article ID Journal Published Year Pages File Type
10963029 Vaccine 2015 5 Pages PDF
Abstract
In these exploratory analyses, 2 doses of HBsAg-1018 induced statistically significantly higher rates of seroprotection than 3 doses of HBsAg-Eng across all subpopulations.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18-70 years of age
Authors
, , , ,